Shr profit seven ct v n/a Net profit 587000 v profit 3231000 Sales 18.5 mln v 18.7 mln Nine Mths Shr loss 39 ct s v n/a Net loss 2368000 v protit 7165000 Sales 55.4 mln v 54.2 mln Note: Current nine month figure include extraordinary loss 1.2 mln dlrs 17 ct share result cost associate restructuring. Prior quarter nine month share figure applicable company operation October 1986 acquisition Gould Inc's GLD> medical product group. Reuter 